The pharma stock leaders can at times seem overly risk averse with their approach to developing new medicines and cures. With the difficulty of clinical trials and the uncertainty of Federal Drug Administration (FDA) approval, many pharma companies prefer to play it safe rather than bet big. But not everyone is content making minor changes forever. There
Stocks to buy
Millionaire-maker hydrogen stocks should be on your watch list. These companies have great upside potential via their strong catalysts and the industry’s progressive acceptance of hydrogen as a clean energy source. We’ll discuss three hydrogen stocks that could mint new millionaires due to their explosive growth trajectories and low market caps. The following companies represent
Don’t look now. But dividends are back in vogue. That could make the so-called Dogs of the Dow strategy — buying the 10 Dow Jones Industrial Average components with the highest yields — a winning bet in 2024. Investors are already flocking back to companies that provide steady income. The Vanguard High Dividend Yield Index
In view of developing times when city panorama becomes intelligent, everyone should know what is at stake in this revolution. The existence of smart cities goes beyond a trend—it’s the reality that defines our present and foresees the future. This transformation does not merely imply technological progress but constitutes a systematic effort toward reinventing city
There are certain economic indicators that capture investors’ attention without fail, and anything suggesting a cooling job market tends to fall toward the top of the list. That’s because the stock market and the unemployment rate are correlated— at least they have been for the most part. When unemployment is high, the economy tends to
As technology advances in our era, biotechnology is not far behind. Modern day medical advancements are impressive, and the company’s making these strides have incredible results to show for it. Let’s take a look at these biotech stocks. Kiniksa (KNSA) Source: aslysun / Shutterstock.com Kiniksa Pharmaceuticals (NASDAQ:KNSA) is like the superhero of the biotech world.
Artificial intelligence (AI) has been the dominant trade in 2023, with no shortage of AI stocks to buy. Just about any stock linked to AI has risen over the last 12 months, from heavyweights such as Microsoft (NASDAQ:MSFT) to smaller start-ups such as C3.ai (NYSE:AI). While some analysts say AI is played out and fully
Cash flow is the lifeblood of durable dividend stocks. When it comes to dividend stocks, there’s an elite tier of companies I like to call the “cash machines.” These stocks have stood the test of time by generating hearty profits on a consistent basis. Further, these companies share that bounty with shareholders year in and
2023 has been mixed for growth stocks but I believe the worst is over. There is high optimism in the stock market as we end the year on a high note. However, if you want to secure your portfolio from such ups and downs and are looking for ways to generate passive income, considering top
It’s been a mixed year for electric vehicle stocks. Global adoption of EVs has continued amidst economic and inflationary headwinds. I believe that temporary headwinds are a good opportunity to accumulate quality EV stocks. Within the broad EV segment, there are some good opportunities among undervalued battery stocks. Let me first talk about the reason
Why is it so hard to find Wall Street’s favorite stocks? It has to do with analysts tending to be bullish about the stocks they cover. According to a September 2023 post by FactSet Vice President and Senior Earnings Analyst John Butters, of the 11,062 ratings of S&P 500 stocks, 54.4% were Buy ratings, 40.0%
With thousands of listed companies, it’s impossible for an investor to be aware of all growth stories. Generally, it’s the stock in news that grabs investor attention. However, there are equally good sleeper stocks that deserve a place in the portfolio. The thing with sleeper stocks is that trading volumes are relatively lower. This does
As the world pivots towards sustainable transportation and energy, batteries have become the cornerstone of modern revolution. Despite the dependence on geographically concentrated and scarce metal resources, the sector remains on the cusp of a major transformation. In its most lucrative long-term market in EVs, breakthroughs, such as solid-state and sodium-ion batteries, could redefine the
You know you want it. High-potential penny stocks that is. And I’m here to deliver. However, from an obligatory standpoint, I must warn you from the get-go: people tend to lose money with this extremely risky endeavor. What compounds the matter is the psychological dynamics involved that can lead you to worsen already bad decisions.
Nvidia (NASDAQ:NVDA) holds a dominant position among U.S.-based artificial intelligence processor producers. Yet, some skeptics might wonder whether NVDA stock can move higher after a blistering 2023. We’re assigning the stock an “A” grade, however, as Nvidia plants its flag in potentially lucrative regional AI-chip markets. It’s a natural evolution for Nvidia to seek new territories to
The stock market is having a great 2023. And what better way to start off 2024 right than to secure your portfolio with some promising end-of-year stock choices. The S&P 500 is up 21% this year, though that’s mostly on the backs of the so-called Magnificent 7 stocks. Combined, those stocks are up around 70%
Backing Nvidia (NASDAQ:NVDA), the leading chip manufacturer in the generative AI boom, has proven lucrative in 2023. The company’s H100 and A100 chips are in high demand. And while these chips may face competition from AMD’s (NASDAQ:AMD) promising new chips, NVDA stock is launching its H200 chips, an upgrade to the H100. These chips are
In the bustling stock markets, the cannabis industry has emerged as a dynamic arena, captivating investors with its promise of rapid evolution and immense growth potential. As the smoke clears from regulatory shifts and market fluctuations, the spotlight shines on three trailblazing cannabis stocks poised for substantial strides in 2024. In the emerging direction, three
Mental health has been one of the hot topics in the medical industry over the past few years. Widespread awareness was brought to the public eye during the COVID-19 pandemic as people in prolonged lockdowns struggled with isolation as well as the threat of a deadly virus. The World Health Organization has issued statements to
Economists’ outlooks of avoiding a recession now seem likely with CPI inflation down to 3.1% for December 2023, marking a slight decrease from the previous month of 3.2%. In light of the recent CPI index data, 67% of economists now believe the economy will not sink into a recession over the next coming year. While